Average Co-Inventor Count = 10.22
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (27 from 822 patents)
2. Abbott Laboratories Corporation (20 from 4,177 patents)
3. The Walter and Eliza Hall Institute of Medical Research (3 from 80 patents)
4. Genentech, Inc. (2 from 3,221 patents)
5. Other (1 from 832,680 patents)
6. Abbvie Bahamas Limited (6 patents)
48 patents:
1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
2. 11786519 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
3. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use
4. 10081628 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
5. 9877958 - Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
6. 9844547 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
7. 9561231 - Pyridinone and pyridazinone derivatives
8. 9315488 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
9. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10. 9266877 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11. 9227963 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
13. 9156856 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
14. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
15. 9073855 - BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases